ELSN — Eleison Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Eleison Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1.72 | -5.8 | -2.73 |
| Depreciation | |||
| Non-Cash Items | -0.006 | 4.31 | 0.445 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.729 | -5.02 | -1.29 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1 | -6.52 | -3.57 |
| Financing Cash Flow Items | — | — | -0.208 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.27 | 11.3 | -0.208 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.73 | 4.81 | -3.78 |